 Tyler Hudish
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 2 | 2022 | 628 | 0.400 |
Why?
| | Bronchial Neoplasms | 1 | 2011 | 14 | 0.380 |
Why?
| | Carmustine | 1 | 2011 | 50 | 0.370 |
Why?
| | Carcinogens | 1 | 2011 | 109 | 0.360 |
Why?
| | Precancerous Conditions | 1 | 2011 | 160 | 0.330 |
Why?
| | Sex Reassignment Surgery | 1 | 2024 | 8 | 0.230 |
Why?
| | Gender Dysphoria | 1 | 2024 | 19 | 0.220 |
Why?
| | Lung Neoplasms | 5 | 2022 | 2344 | 0.190 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4077 | 0.180 |
Why?
| | Intramolecular Oxidoreductases | 3 | 2010 | 68 | 0.160 |
Why?
| | Cytochrome P-450 Enzyme System | 3 | 2010 | 151 | 0.150 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 1050 | 0.150 |
Why?
| | Mental Disorders | 1 | 2024 | 1035 | 0.120 |
Why?
| | PPAR gamma | 2 | 2022 | 183 | 0.110 |
Why?
| | Epoprostenol | 3 | 2010 | 136 | 0.100 |
Why?
| | Blood-Retinal Barrier | 2 | 2002 | 14 | 0.090 |
Why?
| | Administration, Topical | 1 | 2011 | 147 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 211 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1248 | 0.090 |
Why?
| | Neoplasm Invasiveness | 1 | 2011 | 484 | 0.080 |
Why?
| | Receptors, Epoprostenol | 1 | 2008 | 6 | 0.080 |
Why?
| | Quinazolines | 1 | 2010 | 243 | 0.070 |
Why?
| | Mice | 8 | 2022 | 16983 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1872 | 0.070 |
Why?
| | Receptors, Prostaglandin E | 1 | 2006 | 7 | 0.070 |
Why?
| | Growth Substances | 2 | 2002 | 148 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 886 | 0.050 |
Why?
| | Smoke | 1 | 2004 | 140 | 0.050 |
Why?
| | Animals | 8 | 2022 | 35409 | 0.050 |
Why?
| | Desmoglein 3 | 1 | 2022 | 15 | 0.050 |
Why?
| | Formaldehyde | 1 | 2022 | 59 | 0.050 |
Why?
| | Keratin-5 | 1 | 2022 | 50 | 0.050 |
Why?
| | Lung | 3 | 2022 | 3940 | 0.050 |
Why?
| | Capillary Permeability | 1 | 2002 | 141 | 0.050 |
Why?
| | Tubulin | 1 | 2022 | 138 | 0.040 |
Why?
| | Mice, Transgenic | 4 | 2010 | 2135 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 201 | 0.040 |
Why?
| | Retina | 1 | 2002 | 283 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 2000 | 176 | 0.040 |
Why?
| | Female | 5 | 2024 | 68829 | 0.040 |
Why?
| | Dinoprostone | 2 | 2010 | 187 | 0.030 |
Why?
| | Male | 4 | 2024 | 63759 | 0.030 |
Why?
| | Rats | 3 | 2010 | 5487 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2703 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5085 | 0.030 |
Why?
| | Iloprost | 1 | 2008 | 45 | 0.020 |
Why?
| | Cadherins | 1 | 2010 | 190 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 171 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 12467 | 0.020 |
Why?
| | Adenoma | 1 | 2010 | 213 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 931 | 0.020 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2006 | 6 | 0.020 |
Why?
| | Methylcholanthrene | 1 | 2006 | 22 | 0.020 |
Why?
| | Cell Growth Processes | 1 | 2006 | 51 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2010 | 605 | 0.020 |
Why?
| | Butylated Hydroxytoluene | 1 | 2006 | 38 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 310 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2008 | 5468 | 0.010 |
Why?
| | Humans | 4 | 2024 | 129847 | 0.010 |
Why?
| | Leukocytes | 1 | 2006 | 306 | 0.010 |
Why?
| | Genotype | 1 | 2008 | 1829 | 0.010 |
Why?
| | Bronchiolitis | 1 | 2004 | 90 | 0.010 |
Why?
| | Prostaglandins E | 1 | 2002 | 47 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2002 | 78 | 0.010 |
Why?
| | Mannitol | 1 | 2002 | 38 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 756 | 0.010 |
Why?
| | Adult | 1 | 2024 | 35634 | 0.010 |
Why?
| | Cryosurgery | 1 | 2002 | 57 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2004 | 403 | 0.010 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2000 | 26 | 0.010 |
Why?
| | Weight Gain | 1 | 2004 | 510 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2006 | 2888 | 0.010 |
Why?
| | Models, Animal | 1 | 2000 | 376 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2010 | 2045 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2000 | 297 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2002 | 956 | 0.010 |
Why?
| | Ischemia | 1 | 2000 | 405 | 0.010 |
Why?
| | Signal Transduction | 1 | 2010 | 4935 | 0.010 |
Why?
| | Kidney | 1 | 2002 | 1383 | 0.010 |
Why?
|
|
Hudish's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|